Business
Revision Skincare® Appoints Lisa Paley as CEO to Propel the Company’s Next Phase of Growth
IRVING, Texas, September 25, 2025--Revision Skincare®, a leader in advanced skincare solutions, today announced the appointment of Lisa Paley as CEO.
About this update from Haleon Plc
[{"type":"text","content":"Paley Brings Over 25 Years of Leadership Experience Across Consumer Healthcare and Wellness at Haleon, GSK, Pfizer and Johnson & Johnson","length":140,"tagName":"p"},{"type":"text","content":"IRVING, Texas, September 25, 2025--(BUSINESS WIRE)--Revision Skincare®, a leader in advanced skincare solutions, today announced the appointment of Lisa Paley as CEO. A highly experienced, transformational leader, Paley has nearly three decades of executive experience spanning several of the world’s leading consumer healthcare companies, including Haleon, GSK, Pfizer and Johnson & Johnson.","length":396,"tagName":"p"},{"type":"text","content":""Lisa’s extensive experience building science-backed brands across the consumer health, wellness and beauty spectrum makes her the ideal leader to accelerate our business in the US and key global markets," said Matt Farron, Partner, Co-Head of Consumer Group at Gryphon Investors. "She has a stellar reputation as a visionary leader who can deliver sustained growth, scale innovation across geographies and build high-performance cultures with an engaging, people-driven leadership style. We’re thrilled to welcome Lisa to lead Revision Skincare’s next stage of growth."","length":590,"tagName":"p"},{"type":"text","content":"As professional and consumer health and beauty trends continue to intersect, Paley will leverage her expertise building powerhouse consumer brands in the US and globally to reinvigorate Revision Skincare’s business and unlock its full potential. She joins the company from Haleon, the largest global consumer health company, where she served as President of North America and was a founding member of the Executive Leadership Team. During her tenure, she led the company’s North American business through its landmark corporate spin-off from GSK and its public listings on both the NYSE and FTSE.","length":596,"tagName":"p"},{"type":"text","content":""I’m honored to join Revision Skincare as CEO at such an exciting time in the beauty industry, when we’re seeing consumer health and beauty trends converge in new ways," said Paley. "Our brand has a powerful foundation of scientific innovation and proven results, and I look forward to building on that legacy to bring even more transformative skin health solutions to professionals and consumers. At Revision...